Abstract 17-year-old man had been involved in a traffic accident. He underwent a bilateral craniotomy with artificial dura mater to remove bilateral acute subdural hematomas. Seven months later, a right cranioplasty was performed using frozen auto-bone, and he developed extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae meningitis and an epidural abscess. Since his general status was poor, we could not remove the foreign body (artificial dura mater). He was successfully treated with meropenem and chronic suppression with oral trimethoprim-sulfamethoxazole. By describing this case and the results of a review of the pertinent literature, we discuss the importance of ESBL-producing Klebsiella pneumoniae meningitis in posttraumatic/postoperative patients.
Introduction
Klebsiella pneumoniae is an uncommon cause of meningitis. Some studies (1) (2) (3) (4) from Taiwan have reported K. pneumoniae meningitis cases as community-acquired or nosocomial infection. In other countries, K. pneumoniae meningitis is almost always seen in nosocomial or postsurgical patients (5) . Although some cases (2, 4, (6) (7) (8) have been reported, extended-spectrum β-lactamase (ESBL)-producing K. pneumoniae meningitis is very rare. We herein report a case of meningitis and epidural abscess with artificial dura mater caused by ESBL-producing K. pneumoniae and also provide a review of the existing literature.
Case Report
A 17-year-old man was admitted to the emergency room of Kenwakai Otemachi Hospital, September 2009, with multiple trauma caused by a traffic accident. He was in critical condition with bilateral acute subdural hematomas. His vital signs included a blood pressure of 232/92 mmHg, heart rate 100 beats/min, SpO2 79% (O2 10 L/min given), and Glasgow Coma Scale (GCS) E1VTM2. On the day of admission, he underwent a bilateral craniotomy to remove hematomas using artificial dura mater, with a successful outcome. Seven months later, he underwent right cranioplasty using frozen auto-bone. On the fourth postoperative day, he presented with a fever (40 ), consciousness disorder, and neck stiffness. His vital signs were as follows: blood pressure 155/99 mmHg, heart rate 114 beats/min, respiratory rate 25 breaths/ min, SpO2 95% (room air), and GCS E4V4M5. Although the gross appearance of the cerebrospinal fluid (CSF) was cloudy, Gram staining was negative. An analysis of the CSF revealed a white blood cell (WBC) count of 2,780/μL, polymorphonuclear leukocytes 2,098/μL, protein 356 mg/dL, and glucose 1 mg/dL. We diagnosed postoperative meningitis as a surgical site infection, then started cefepime at 2 g intravenously every 8 hours, linezolid at 600 mg intravenously every 12 hours and gentamicin at 3 mg intrathecally once Division of Infectious Diseases, Kenwakai Otemachi Hospital, Japan daily. Since his body weight was 68 kg and serum creatinine was 0.5 mg/dL (normal renal function), no dose adjustment was required.
On the seventh postoperative day, the patient's CSF culture became positive for ESBL-producing K. pneumoniae. ESBL was identified using the disk diffusion method. This strain was sensitive to imipenem/cilastatin (MIC !1 μg/ mL), trimethoprim-sulfamethoxazole (TMP-SMX) (MIC ! 2 μg/mL), amikacin (MIC !16 μg/mL), and was resistant to gentamicin (MIC >8 μg/mL) and intermediately resistant to levofloxacin (MIC = 4 μg/mL) ( Table 1) . A susceptibility test was performed using the Microscan WalkAway 96 Plus system (Siemens Japan K.K., Tokyo, Japan). We changed the antibiotics to 2 g of meropenem given intravenously every 8 hours and amikacin given at 30 mg intrathecally once daily. On the ninth postoperative day, the patient's CSF culture became negative for K. pneumoniae. We continued to administer meropenem for 32 days and amikacin for 5 days.
After treatment with meropenem, magnetic resonance imaging confirmed the presence of an epidural abscess. Although reoperation for drainage and removing the artificial dura mater was considered, his general condition was relatively poor, and it was thought that the patient would not have withstood this procedure. We decided to prescribe oral antibiotics (TMP-SMX 20 mg/kg/day, dose based on the trimethoprim component) after the treatment with meropenem, based on the antibiotic susceptibility of this strain. After 19 days (60th postoperative day), pancytopenia occurred (WBC 2,000/μL, hemoglobin 11.4 g/dL, platelets 68,000/μL), and TMP-SMX was discontinued. On the 82nd postoperative day, since his hematological parameters had recovered to normal, TMP-SMX at 2.5 mg/kg/day (dose based on the trimethoprim component) was started again for chronic suppression. The patient was discharged on the 166 th postoperative day and transferred to another hospital. He recovered from a bedridden state to walking with a cane. The administration of TMP-SMX is ongoing. Based on discussions held between infectious diseases physicians, neurosurgeons, the patient, and his family, we decided to use oral TMP-SMX for approximately 2-3 years. We considered the possibility of recurrence, the potential problems associated with an operation for drainage and removal of the foreign body, the possible decrease in his ADL, the adverse effects of the drug, the cost of the drug, and both his requests and those of his family.
Discussion
ESBL-producing gram-negative bacilli (GNB) are resistant to most β-lactam drugs, and carbapenems are the best antibiotics used to treat them (9) . As with many other countries, ESBL-producing GNB are an increasing health threats in Japan. A worldwide survey (10) tested a collection of GNB from intra-abdominal infections, and revealed that 18% of K. pneumoniae produced ESBL. A Japanese domestic survey (11) performed in 2006 indicated that the prevalence of ESBL-producing K. pneumoniae strains (clinical isolates) was only 2.4%. However, Chong's report (12) warned of an increased detection of ESBL strains in Japan. In a single center study, the prevalence of ESBL-producing K. pneumoniae increased from 0.9% in 2003 to 10.5% in 2009 (12) . In the three months between October and December 2011, 21.3% of clinically isolated K. pneumoniae strains in our hospital were found to produce ESBL. This high prevalence might have been caused by the admission of many elderly patients (13) to our hospital.
Some cases of ESBL-producing K. pneumoniae meningitis treated with antibiotics have been reported. We searched the English literature using PubMed and have summarized the features of these cases (2, 4, (6) (7) (8) in Table 2 . Based on the patient information we obtained, five cases were posttrauma and/or postoperative. This was compatible with the status of our patient, but there were no other cases showing the formation of an epidural abscess. The portal of entry for K. pneumoniae was not clarified, but two hypotheses have been found in the literature. Price et al. (14) described nine patients with Klebsiella meningitis after trauma or surgery in their neurosurgical unit. They isolated the same organism from the sputum or throat of five patients (55.5%) before or at the same time that the meningitis had occurred. Based on these results, direct spread from the respiratory tract was suspected. O'Neill et al. (15) developed another theory. They reported 40 post-neurosurgical GNB meningitis episodes and found that 39 episodes (97.5%) had pre-existing external ventricular drains or V-P shunts, which suggested that prosthetic devices had been the entry sites for GNB. Because specimens from the respiratory tract of our patient were not tested, it was unknown whether ESBL-producing 
K. pneumoniae were present in his respiratory tract. However, our case supports that a pre-existing external ventricular drain and existing artificial dura mater might be risk factors for ESBL K. pneumoniae invasion. The Infectious Diseases Society of America (IDSA) guideline recommends meropenem for the treatment of meningitis caused by ESBL-producing GNB (16) , and four of the previous cases were treated with carbapenems (2, 4, 7) . It is widely known that meropenem penetrates into the cerebrospinal fluid when there is meningeal inflammation (17) . This guideline recommends a duration of treatment of 21 days for aerobic GNB (16) . We started antibiotics in the acute phase according to this recommendation. In terms of the carbapenems, imipenem/cilastatin is the only agent included in the routine antibiotic resistance test performed in the laboratory of our hospital. We inferred that this strain was susceptible to meropenem based on its sensitivity to imipenem/cilastatin.
TMP-SMX (10-20 mg/kg/day) as an alternative drug against Enterobacteriaceae meningitis is recommended (16) , and some previous reports support its use (18) (19) (20) . Oral TMP-SMX has good bioavailability with a ratio of absorption of 90 to 100%. In addition, the ratio of the serum to CSF concentration for TMP ranges from 13 to 53%, and that for SMX ranges from 19 to 63% (21) .
ESBL-producing organisms are frequently resistant to non β-lactam antibiotics because they carry genes encoding resistance factors (22) (23) (24) . Procop et al. (25) compared the antibiotic susceptibility between ESBL-producing and non-ESBL-producing K. pneumoniae. Of the ESBL-producing strains, 56% (23/41 isolates) were susceptible, compared with 82% (34/41 isolates) of non-ESBL-producing strains (p <0.01). Based on these results, we considered TMP-SMX to be valid in the present case, but not in all similar cases. We found no evidence, even in the past reports, that supported suppressive therapy for an epidural abscess with an artificial dura mater.
In conclusion, when beginning empirical therapy, it is important to consider the possibility that a posttrauma and/or postoperative patient's CNS infection might be caused by ESBL-producing K. penuemoniae.
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